BlackRock’s OncoSec Medical Incorporated ONCS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,410
| Closed | -$3.64K | – | 5725 |
|
|
2023
Q1 | $3.64K | Buy |
1,410
+1
| +0.1% | +$2 | ﹤0.01% | 5397 |
|
|
2022
Q4 | $2.37K | Buy |
1,409
+1
| +0.1% | +$6 | ﹤0.01% | 5587 |
|
|
2022
Q3 | $16K | Sell |
1,408
-649
| -32% | -$9.75K | ﹤0.01% | 5549 |
|
|
2022
Q2 | $33K | Sell |
2,057
-2,277
| -53% | -$43.7K | ﹤0.01% | 5487 |
|
|
2022
Q1 | $110K | Sell |
4,334
-143
| -3% | -$3.02K | ﹤0.01% | 5266 |
|
|
2021
Q4 | $95K | Buy |
4,477
+79
| +2% | +$2.67K | ﹤0.01% | 5289 |
|
|
2021
Q3 | $206K | Sell |
4,398
-63
| -1% | -$3.19K | ﹤0.01% | 4980 |
|
|
2021
Q2 | $276K | Buy |
4,461
+1,614
| +57% | +$146K | ﹤0.01% | 4830 |
|
|
2021
Q1 | $298K | Buy |
2,847
+96
| +3% | +$13.1K | ﹤0.01% | 4677 |
|
|
2020
Q4 | $391K | Buy |
2,751
+1,435
| +109% | +$153K | ﹤0.01% | 4382 |
|
|
2020
Q3 | $98K | Sell |
1,316
-1,105
| -46% | -$86.1K | ﹤0.01% | 4519 |
|
|
2020
Q2 | $109K | Buy |
2,421
+941
| +64% | +$40K | ﹤0.01% | 4480 |
|
|
2020
Q1 | $42K | Hold |
1,480
| – | – | ﹤0.01% | 4509 |
|
|
2019
Q4 | $59K | Hold |
1,480
| – | – | ﹤0.01% | 4516 |
|
|
2019
Q3 | $64K | Hold |
1,480
| – | – | ﹤0.01% | 4507 |
|
|
2019
Q2 | $82K | Sell |
1,480
-686
| -32% | -$66K | ﹤0.01% | 4507 |
|
|
2019
Q1 | $265K | Sell |
2,166
-43
| -2% | -$5.87K | ﹤0.01% | 4203 |
|
|
2018
Q4 | $311K | Buy |
2,209
+1,095
| +98% | +$275K | ﹤0.01% | 4150 |
|
|
2018
Q3 | $344K | Buy |
1,114
+28
| +3% | +$8.61K | ﹤0.01% | 4207 |
|
|
2018
Q2 | $330K | Buy |
1,086
+1,009
| +1,310% | +$354K | ﹤0.01% | 4199 |
|
|
2018
Q1 | $32K | Buy |
77
+7
| +10% | +$2.87K | ﹤0.01% | 4503 |
|
|
2017
Q4 | $25K | Buy |
70
+2
| +3% | +$701 | ﹤0.01% | 4538 |
|
|
2017
Q3 | $14K | Buy |
68
+4
| +6% | +$891 | ﹤0.01% | 4646 |
|
|
2017
Q2 | $17K | Sell |
64
-179
| -74% | -$43.9K | ﹤0.01% | 4681 |
|
|
2017
Q1 | $68K | Buy |
+243
| New | +$70.7K | ﹤0.01% | 4408 |
|
BlackRock's ONCS Position: Q2 2023 in Review
BlackRock sold out of OncoSec Medical Incorporated (ONCS) in Q2 2023, closing a stake of 1,410 shares — an estimated $3.64K sold.
BlackRock first reported a position in ONCS in Q1 2017 and held it in 25 quarters. The position peaked at $391K in Q4 2020. 0 funds tracked by Wall St. Rank hold ONCS as of Q2 2023.
- BlackRock reported no remaining OncoSec Medical Incorporated position as of Q2 2023 after selling out during the quarter.
- BlackRock sold 1,410 OncoSec Medical Incorporated shares in Q2 2023, an estimated $3.64K.
- BlackRock first reported a position in OncoSec Medical Incorporated in Q1 2017 and held it in 25 quarters.
- BlackRock's OncoSec Medical Incorporated position peaked at $391K in Q4 2020.
- 0 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2023.
Based on BlackRock's 13F filing for Q2 2023, filed 11 Aug 2023.